| Ambetter Health Texas Superior Marketplace Clinical | Valbenazine | 2025-12-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Tiopronin Delayed-Release | 2025-12-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Valbenazine | 2025-12-01 |
| UHC Commercial Medical & Drug | Benlysta® (Belimumab) – Commercial Medical Benefit Drug Policy | 2025-12-01 |
| UHC Commercial Medical & Drug | Evenity® (Romosozumab-Aqqg) – Commercial Medical Benefit Drug Policy | 2025-12-01 |
| UHC Commercial Medical & Drug | Ophthalmologic Complement Inhibitors – Commercial Medical Benefit Drug Policy | 2025-12-01 |
| UHC Commercial Medical & Drug | Preventive Vaccines (Immunizations) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2025-12-01 |
| UHC Commercial Medical & Drug | Rebyota® (Fecal Microbiota, Live-Jslm) – Commercial Medical Benefit Drug Policy | 2025-12-01 |
| UHC Commercial Medical & Drug | Review at Launch for New to Market Medications – Commercial Medical Benefit Drug Policy | 2025-12-01 |
| UHC Commercial Medical & Drug | Zolgensma® (Onasemnogene Abeparvovec-Xioi) – Commercial Medical Benefit Drug Policy | 2025-12-01 |